Award
National Cancer Institute 5R44CA285041-03
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
Recipient
Binary Genomics, Inc.
Award Amount
$1,009,228.00
Ceiling
$1,009,228.00
Awarded
August 14, 2025
Identifier
5R44CA285041-03
Award for developing a blood test to monitor lung cancer immunotherapy response using cell-free DNA, funded by the National Cancer Institute under NIH grant PA-23-230.
Description
The project involves developing a blood test to monitor immunotherapy response in lung cancer patients using epigenetic features in cell-free DNA. The award is part of NIH grant PA-23-230 and funded by the National Cancer Institute. The project duration is approximately 3 years and aims to support clinical utility and standardize testing for lung cancer immunotherapy monitoring.